Alnylam Pharmaceuticals, Inc. - Common Stock (NQ:ALNY)
296.31
-4.20
(-1.40%)
Streaming Delayed Price
Updated: 1:30 PM EDT, May 22, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 231,892 |
| Open | 299.12 |
| Bid (Size) | 296.16 (80) |
| Ask (Size) | 296.34 (40) |
| Prev. Close | 300.51 |
| Today's Range | 294.99 - 303.33 |
| 52wk Range | 284.19 - 495.55 |
| Shares Outstanding | 118,847,693 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Alnylam (ALNY) Q1 2026 Earnings Transcript ↗
April 30, 2026
Alnylam to Webcast TTR Investor Webinar
March 10, 2026
Frequently Asked Questions
Is Alnylam Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Alnylam Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Alnylam Pharmaceuticals, Inc. - Common Stock trade on?
Alnylam Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock is ALNY on the Nasdaq Stock Market
What is the current price of Alnylam Pharmaceuticals, Inc. - Common Stock?
The current price of Alnylam Pharmaceuticals, Inc. - Common Stock is 296.31
When was Alnylam Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Alnylam Pharmaceuticals, Inc. - Common Stock was at 05/22/26 01:30 PM ET
What is the market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock is 35.22B
How many shares of Alnylam Pharmaceuticals, Inc. - Common Stock are outstanding?
Alnylam Pharmaceuticals, Inc. - Common Stock has 35B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube